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CD14 Directs Adventitial Macrophage Precursor Recruitment: Role in
Early Abdominal Aortic Aneurysm Formation
Andra L. Blomkalns, MD; Daniel Gavrila, MD; Manesh Thomas, MD; Bonnie S. Neltner, BS; Victor M. Blanco, PhD;
Stephanie B. Benjamin, BA; Michael L. McCormick, PhD; Lynn L. Stoll, PhD; Gerene M. Denning, PhD; Sean P. Collins, MD, MPH;
Zhenyu Qin, PhD; Alan Daugherty, PhD; Lisa A. Cassis, PhD; Robert W. Thompson, MD; Robert M. Weiss, MD; Paul D. Lindower, MD;
Susan M. Pinney, PhD; Tapan Chatterjee, MD; Neal L. Weintraub, MD
Background-—Recruitment of macrophage precursors to the adventitia plays a key role in the pathogenesis of abdominal aortic
aneurysms (AAAs), but molecular mechanisms remain undeﬁned. The innate immune signaling molecule CD14 was reported to be
upregulated in adventitial macrophages in a murine model of AAA and in monocytes cocultured with aortic adventitial ﬁbroblasts
(AoAf) in vitro, concurrent with increased interleukin-6 (IL-6) expression. We hypothesized that CD14 plays a crucial role in
adventitial macrophage precursor recruitment early during AAA formation.
Methods and Results-—CD14/ mice were resistant to AAA formation induced by 2 different AAA induction models: aortic
elastase infusion and systemic angiotensin II (AngII) infusion. CD14 gene deletion led to reduced aortic macrophage inﬁltration and
diminished elastin degradation. Adventitial monocyte binding to AngII-infused aorta in vitro was dependent on CD14, and
incubation of human acute monocytic leukemia cell line-1 (THP-1) monocytes with IL-6 or conditioned medium from perivascular
adipose tissue (PVAT) upregulated CD14 expression. Conditioned medium from AoAf and PVAT induced CD14-dependent
monocyte chemotaxis, which was potentiated by IL-6. CD14 expression in aorta and plasma CD14 levels were increased in AAA
patients compared with controls.
Conclusions-—These ﬁndings link CD14 innate immune signaling via a novel IL-6 ampliﬁcation loop to adventitial macrophage
precursor recruitment in the pathogenesis of AAA. ( J Am Heart Assoc. 2013;2:e000065 doi: 10.1161/JAHA.112.000065)
Key Words: abdominal aortic aneurysm • CD14 • innate immunity • macrophage • perivascular adipose tissue
A bdominal aortic aneurysm (AAA) disease is a frequentcause of morbidity and mortality, occurring in up to
12.5% and 5.2% of elderly men and women, respectively.
Roughly 25 000 AAA repairs are performed each year, and
despite the progress made in primary preventive measures
and screening programs, AAAs account for >13 000 deaths
annually in the United States.1 Only 21% to 33% of patients
with aortic rupture survive to surgery, with an additional 50%
mortality following surgery.2 Risk factors associated with AAA
include older age, smoking, male sex, hypertension, and the
presence of atherosclerotic disease in coronary or peripheral
arteries.3,4 Despite the frequency and associated morbidity
and mortality of AAA, the speciﬁc cellular mechanisms that
underlie aneurysm formation and progression are poorly
understood.
The immune system plays a key role in the pathogenesis of
atherosclerosis and AAA. In the case of atherosclerosis,
monocyte adhesion to inﬂamed endothelium is one of the
earliest pathological features, followed by macrophage uptake
of lipoproteins, leading to foam cell formation within the
intima. The innate immune system, which is the genetically
conserved, nonspeciﬁc ﬁrst line of defense in the recognition
of pathogens, has been linked to atherosclerosis in exper-
imental animal models and in humans. For example, endo-
toxin (LPS) levels in the blood are strongly and independently
associated with atherosclerosis in humans, and endotoxin
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injections augment atherosclerotic lesion development in
animal models.5–8 Moreover, deletions of Toll-like receptor 4
(TLR4) or its adaptor protein, MyD88, both of which play a
crucial role in innate immune signaling, ameliorate athero-
sclerosis in mice.9,10
As in atherosclerosis, inﬂammation is central to AAA
formation, but the speciﬁc role of the components of the
innate immune system is less clear. Owens et al11 recently
reported that deﬁciency of TLR4 or MyD88 reduced both
angiotensin II (AngII)–induced atherosclerosis and AAA for-
mation, indicating that innate immune signaling may contrib-
ute to the pathogenesis of AAA. In AAA, macrophages are
recruited prominently to the adventitia and media, where they
secrete proteases that lead to matrix degradation, smooth
muscle cell apoptosis, tissue weakening, and aortic enlarge-
ment.12,13 Macrophage precursor recruitment to the adven-
titia during AngII-induced AAA formation was reported to be
dependent on adventitial secretion of interleukin-6 (IL-6) and
monocyte chemotactic protein-1 (MCP-1) and of CCR2
expression in monocytes.14 The macrophages accumulating
in aortic adventitia were CD14hi and F4/80, consistent with
activated macrophages. Moreover, CD14 expression in mono-
cytes in vitro was upregulated by coculture with ﬁbroblasts,
concurrent with increased secretion of IL-6 and MCP-1.
CD14 is a 55-kDa GPI-linked surface protein pattern
recognition receptor that plays a central role in activation of
the innate immune system through transduction of signals
from bacterial LPS and various other ligands. CD14 is most
known for its participation in signal transduction through TLR4
and, to a lesser extent, TLR2.15,16 Moreover, activated
monocytes shed a soluble form of CD14 (sCD14) into the
bloodstream, and levels of sCD14 have been shown to
correlate with increased aortic stiffness in humans, further
suggesting a role in vascular pathology.17–19
We hypothesized that CD14 plays a crucial role in
macrophage precursor recruitment and thereby early aortic
inﬂammation, leading to AAA formation. To test this hypoth-
esis, we investigated the impact of CD14 gene deletion on AAA
formation and aortic pathology in 2 distinct murine models and
in in vitro experiments with macrophage migration. To
investigate our hypothesis in humans, we examined whether
CD14 expression is locally enhanced in AAA and whether
humans with AAA exhibit increased levels of sCD14 in plasma
compared with age- and sex-matched controls without AAA.
Methods
Elastase Infusion Murine AAA Model
Three- to 6-month-old (within 4 weeks of age for any 1
experimental set) C57Bl/6 (CD14+/+) and CD14/ on a
C57Bl/6 background (Jackson) underwent the elastase model
of aneurysm induction as previously described.20 All animals
(CD14+/+, n=4; CD14/, n=5) were treated with elastase
from the same lot. Heat-inactivated (100°C95 minutes)
elastase served as the control (n=3). After 14 days, the aorta
was reexposed, and ﬁnal AD measurements were obtained.
For individual animals, AAA was deﬁned as an increase in
diameter of ≥50% greater than the preperfusion diameter.
AngII Infusion Murine AAA Model
For AngII experiments, apoE//CD14/ mice were gener-
ated using apoE / CD14+/ breeding pairs (Jackson).
ApoE//CD14+/+ littermates were used as controls. Three-
to 6-month-old apoE/CD14+/+ and apoE/CD14/ mice
(within 4 weeks of age for any 1 experimental set) were
subjected to a 14-day infusion of AngII (1000 ng/kg per
minute) via subcutaneous osmotic minipumps (Model 2002,
Durect Corporation) as described previously.20 Mice (CD14+/+,
n=16; CD14/, n=7; saline-infused controls, n=7) were
euthanized after 14 days, and the abdominal aortas were
exposed, measured in situ with digital calipers, and collected.
Histological Studies
Formalin-ﬁxed, parafﬁn-embedded tissue sections from
mouse and human aortas were stained with hematoxylin
and eosin and Verhoeff–van Gieson (VVG) stain (elastin).
Primary antibodies included rabbit anti-mouse CD14 (Santa
Cruz M-305; 1:100); mouse anti-human CD68 (Dako; Clone
PG-M1; 1:100); rat anti-mouse Mac-3 antibody (BD Pharmin-
gen; 1:100); rabbit anti-human CD14 (Epitomics; 1:200).
Species and isotype-matched antibodies were used as
controls in the mouse studies. In human studies, omission
of the primary antibody served as the negative control.
Zymographic Analysis of Matrix
Metalloproteinase MMP-2 and MMP-9 Activity
MMP-2 and MMP-9 activity was determined by zymography as
described previously.21 Brieﬂy, prepoured 10% polyacrylamide
gels containing 0.1% gelatin A were purchased (Bio-Rad) and
used as the substrate for MMP activity. Equivalent amounts of
samples were loaded on the basis of protein content (Bradford
assay; Bio-Rad).
Image Quantiﬁcation
ImageJ software (version 1.42; National Institutes of Health)
was used for quantitative analysis. Bands were quantiﬁed on
the basis of their relative intensities. Each aorta image was
scanned in 4 nonoverlapping ﬁelds, and average values are
reported in the Table.
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Cell Isolation and Culture
All cell isolation and culture experiments were performed in
triplicate. Human acute monocytic leukemia cell line-1 (THP-1)
monocytic cells (ATCC) were cultured, and expression of
CD14 was induced by calcium supplementation for 3 days.
Mouse peritoneal macrophages were harvested 4 days after
injection of 3% thioglycollate. Human aortic adventitial
ﬁbroblasts (AoAf) obtained from Lonza were grown in
recommended medium. Conditioned medium was collected
and stored at 80°C after culturing subconﬂuent cells.
To investigate the dependence of vascular monocyte binding
on CD14, we incubated ﬂuorescently labeled macrophage
precursors with aorta vessel explants as previously
described.22 ApoE/mice were infused with AngII for 4 days,
and aortas were removed, segmented, and incubated in vitro
with ﬂuorescently labeled CD14+/+ or CD14/ macrophages
(200 000 cells in 100 lL of medium) for 2 hours. Embedded
aortic segments were sectioned in 10-lm sections. For every 2
aortic segments (ie, each well), macrophages bound to the
adventitia and intima were counted and averaged.
Cell Migration Experiments
THP-1 cells and mouse peritoneal macrophages were used in
this set of experiments. All experiments were performed in
triplicate. LAM and MCP-1 served as positive and negative
controls, respectively, for CD14-dependent responses.23
Migration to conditioned media from human AoAf and PVAT
was studied. THP-1 cells were incubated with isotypic IgG2 or
anti-CD14 (MY4; Beckman Coulter) monoclonal antibodies,
and cell migration was assayed with chemotaxis chambers
(Neuro Probe, Inc) in triplicate. Results are expressed as
percent increase in migration relative to migration toward the
control medium.
Flow Cytometry
THP-1 cells were used to measure levels of CD14 expression
after incubation with varying concentrations of IL-6, MCP-1,
osteopontin, or conditioned medium from PVAT. These
experiments were performed in triplicate. Cells were incu-
bated with human CD14-FITC antibody (CD14, Mouse Anti-
Human, FITC, Invitrogen) to detect CD14 expression, and
mouse IgG2a isotype (Mouse, IgG2a, FITC, Invitrogen) was
used as a control. All samples were analyzed using CELL
Quest Pro Software, and data are reported in compliance with
MIFlowCyt standards.24
Human AAA Specimens
Aneurysmal and adjacent nonaneurysmal human aorta sam-
ples were obtained during surgery from 3 patients undergoing
AAA repair. Removal of these tissues was accomplished as
Table. Summary of Image Quantiﬁcations
Manuscript Reference Measurement Control Genotype CD14+/+ Genotype CD14/ P Value
Elastase H and E (Figure 1B) Average particles
(PMNs)/ﬁeld
133.2* (CD14+/+ HI elastase) 206.5 153.3 0.03
Elastase Mac-3 (Figure 1B) Average particles
(macs)/ﬁeld
41.25* (CD14+/+ HI elastase) 161.43 60.75 0.04
Elastase VVG (Figure 1B) Elastin band
area/ﬁeld (lm2)
151 9698134* (CD14+/+ HI elastase) 116 9366841 142 87327 497 <0.001
AngII H and E (Figure 2C) Average particles
(PMNs)/ﬁeld
306.0 183.66 0.08
AngII Mac-3 (Figure 2D) Brown stain/ﬁeld 111.4 (thoracic) 183.0 (abd) 0.04
Zymogram elastase model MMP-2, area% 7.650.38 5.310.77 0.04
Zymogram elastase model MMP-9, area% 4.600.32 2.800.61 0.04
Zymogram AngII model MMP-2, area% 9.260.41 8.600.78 0.49
Zymogram AngII model MMP-9, area% 3.910.40 3.240.87 0.25
Condition or location
IL-6 migration (Figure 3C) Blue ﬂuorescence 393.4 (LAM only) 776.7 (LAM+IL-6) Single image
All images from this set of experiments were quantiﬁed using the publically available NIH Image J/FIJI software. Four similar ﬁelds per sample were quantiﬁed and the values averaged
according to standard instructions of Image J/FIJI densitometry software (“Madison,” National Institutes of Health, Bethesda, MD). Quantiﬁcations include number of cells, density, and
percent area affected and are designated in the Measurement column. Controls include vehicle administration and/or wild-type genotype and are designated in the labeled columns.
Standard errors and statistics are provided where applicable. PMN indicates polymorphonuclear; VVG, Verhoeff–van Gieson stain; H and E, hematoxylin and eosin; AngII, angiotensin II;
MMP, matrix metalloproteinase; IL, interleukin; AAA, abdominal aortic aneurysm; LAM, lipoarabinomannan.
*Heat-inactivated (HI) elastase control in the elastase AAA model.
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part of the normal operative procedure, in which both
aneurysm and adjacent nonaneurysmal segments were
trimmed in preparation for graft anastomosis. These were
initially ﬁxed and parafﬁn-embedded and then mounted in
5-lm sections. CD14 was detected by a polyclonal goat anti-
mouse CD14 antibody (sc-6999; Santa Cruz Biotechnology,
Santa Cruz, CA) and then processed with a commercial
immunoperoxidase staining kit (Vectastain Elite ABC Kit;
Vector Labs). In these experiments, specimens incubated with
no primary antibody served as negative controls.
Measurement of Soluble CD14 in Human Serum
Human serum samples were obtained from the Fernald Medical
Monitoring Program population cohort.25,26 The Fernald data
are part of a longitudinal medical monitoring program that
includes collection of routine serum samples. These patients
are not part of a blinded, controlled trial but rather an
observational cohort. We obtained human samples from this
diverse population over a 20-year period. In that these patients
were not selected on the basis of any study-related inclusion or
exclusion criteria (except living in the Fernald affected area), 21
patients with AAA documented by imaging (CT scan or
ultrasound) or surgical pathology were identiﬁed through
medical record review. Controls (n=28) consisted of age- and
sex-matched patients without AAA (n=21) as documented by
imaging studies. Soluble CD14 (sCD14) levels were determined
using a CD14 ELISA assay kit (R&D Systems). The nonpara-
metric Mann–Whitney U test was used to compare the sCD14
levels between cases and controls.
Approvals
All protocols were approved by the Institutional Animal Care
and Use Committees and Review Boards at the Universities of
Iowa and Cincinnati.
Statistical Analysis
Results are expressed as meanSEM. Group differences were
analyzed by the Student t test and multiple groups by 1-way
ANOVA. Fisher’s exact test was used to analyze categorical
data. P<0.05 was considered signiﬁcant.
Results
To determine the effects of CD14 gene deletion on experi-
mental aneurysm formation, we employed 2 widely accepted
yet disparate murine models: (1) intra-aortic infusion of
elastase in CD14+/+ and CD14/ mice and (2) infusion of
AngII via an osmotic minipump in hyperlipidemic apoE/
mice.20 We chose to examine aortic changes at an earlier
point, 14 days, as opposed to the previously published and
more common 28-day experiments. Both models historically
yield AAAs in >90% of mice and exhibit pathological evidence
of inﬂammation and matrix degradation, typical features of
human AAAs. Image quantiﬁcation was performed on micro-
scopic sections (Table).
Deletion of CD14 Gene Prevented AAA Formation
in Elastase-Infused Mice
We sought to determine if CD14 deletion would attenuate
aneurysm formation in a murine AAA model that was
independent of atherosclerosis, hypertension, and hyperlipid-
emia. Infusion of elastase induced an increase in ﬁnal aortic
diameter in CD14+/+ mice, consistent with AAA formation. In
contrast, none of the CD14/ mice developed AAAs
following elastase infusion (Figure 1A).
CD14 Deletion Attenuated Inﬂammatory Cell
Inﬁltration
Examination of aortic histology by H&E staining (Figure 1B, A
through C) showed marked inﬂammatory cell inﬁltration in the
CD14+/+ mice infused with elastase, particularly in the
adventitial region, which was attenuated in CD14/ mice.
Many of these adventitial cells stained positively for MAC-3, a
macrophage-speciﬁc antibody (Figure 1B, D through F) in
elastase-infused CD14+/+ mice, whereas minimal staining was
observed inCD14/mice. VVGstaining (Figure 1B,G through I)
demonstrated that elastin bands were largely preserved in
control mice, which received heat-inactivated elastase, and
likewise in elastase-infused CD14/ mice. In contrast, subtle
elastin band ﬂattening and straightening of the wavelike
appearance were observed in elastase-infused CD14+/+ mice.
Also,MMP-2andMMP-9activitywasslightlyreducedinelastase-
infused CD14/mice compared with CD14+/+ mice (Table).
Deletion of CD14 Gene Reduced Incidence
and Severity of Aneurysms in AngII-Infused
ApoE/ Mice
In this set of experiments we sought to determine the effect
of CD14 deletion in a different model of AAA formation.
Subcutaneous infusion of AngII for 2 weeks produced AAAs in
92% and thoracic aortic aneurysms (TAAs) in 42% of apoE/
mice, whereas no animals infused with saline developed AAA.
Deletion of CD14 reduced the incidence of AAAs and TAAs
induced by AngII infusion as well as aneurysm diameter and
weight (Figure 2A). Blood pressure measurements did not
differ between the CD14/ animals and the CD14+/+
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animals (Table). Representative pictures of aortas from these
animals are shown in Figure 2B. Aneurysms in this model
typically form in the suprarenal aorta in conjunction with a
thrombus. In addition, AAA pathology (assessed using a
standardized pathology scoring system that takes into
account the number of discrete aneurysms and the presence
of thrombus formation)27 was diminished in the CD14/ mice.
MMP-2/9 activity (Table) did not differ between the 2 groups.
CD14 Deletion Attenuated Inﬂammatory Cell
Inﬁltration in AngII-Infused apoE/ Mice
As macrophages are indispensable for AAA development and
macrophage precursor inﬁltration may be an initial step in
AAA formation in this model,20,28 we examined the extent of
macrophage accumulation within aortic segments. In AngII-
infused apoE/ mice, aortas displayed evidence of increased
wall thickness and inﬂammatory cell inﬁltration, particularly in
the adventitial region, which was strongly abrogated in mice
lacking CD14 (Figure 2C). Many of the inﬂammatory cells
inﬁltrating the adventitia of AngII-infused apoE/ mice
stained positively for a macrophage marker (Figure 2D).
Serum monocyte proportions of the total white blood cell
count did not differ between CD14+/+ and CD14/ mice
(3112% and 4510%, respectively, P=NS). Notably, macro-
phage inﬁltration was much less in nonaneurysmal thoracic
aortic segments from these same mice. These results indicate
that adventitial macrophage inﬁltration is colocalized to the
site of AAA formation in this model.
Next, we investigated the role of CD14 in aortic macro-
phage precursor recruitment after only 4 days of AngII
infusion, early during the course of AAA formation, using an
in vitro assay.22,29 Avid binding of CD14+/+, but not CD14/,
macrophage precursors to aortic explant adventitia was
detected (Figure 2E) in comparison with the luminal surface.
These results conﬁrm that CD14 expression in monocytes and
macrophage precursors is crucial for their recruitment to
adventitia early during AngII-infused AAA formation.
IL-6 Ampliﬁed CD14 Expression and
CD14-Dependent Monocyte Migration
Prior studies have suggested that IL-6, a key cytokine in AAA,
upregulates CD14 expression as part of a feed-forward
inﬂammatory loop.14 We observed that IL-6 dose-dependently
upregulated CD14 expression in human THP-1 monocytic
cells (Figure 3A). CD14 expression was likewise increased by
exposure to conditioned medium from PVAT, which directly
abuts the vascular adventitia and is a rich source of IL-6.30
This suggests that PVAT could play a role in upregulating
adventitial CD14 expression during AAA formation. In con-
trast, neither MCP-1 nor osteopontin, 2 cytokines, which have
likewise been implicated in AAA formation,14,31 affected CD14
expression in THP-1 cells (data not shown).
THP-1 chemotaxis was used to investigate the role of
CD14 in human monocyte migration. Migration to conditioned
media from human AoAf and PVAT was partially inhibited by
the CD14-blocking antibody (Figure 3B). Likewise, in murine
A
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A
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m
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 (m
m
) *
* p<0.05 between pre- and post- elastase infusion
Post elastase treatment
B
Figure 1. A, Deletion of CD14-attenuated elastase-induced AAA formation (CD14+/+, n=4; CD14/, n=5). B, Representative aortic histology
demonstrating inﬂammatory cell inﬁltration (top), macrophages (middle), and elastin band staining (bottom). The luminal side of the vessel is to
the right in the images. Heat-inactivated elastase in CD14+/+ (n=3) was used to control for surgical manipulation. Image quantiﬁcation revealed a
signiﬁcant difference in macrophage inﬁltration and elastin degradation between CD14+/+ and CD14/ animals (shown in Table). AAA indicates
abdominal aortic aneurysm; H&E, hematoxylin and eosin; VVG, Verhoeff–van Gieson stain.
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peritoneal macrophages (Figure 3B, right), CD14 gene deletion
attenuated migration to LAM- and PVAT- conditioned media.
Finally, preincubation with IL-6 potentiated LAM-induced
migration, consistent with enhanced CD14-dependent
migratory responses. Moreover, migration induced by
AoAf-conditioned medium was potentiated by preincubation
Saline infusion 
apoE -/-
CD14+/+o
AngIl infusion
apoE -/-
CD14+/+o
AngII infusion
apoE -/-
CD14-/-o
AngII apoE -/-
CD14+/+
AngII apoE-/-
CD14-/-B
A
C
D
E
AngII Thoracic 
segment (non-
aneurysmal)
AngII AAA 
segment
Saline CD14+/+ 
macs
AngII CD14+/+ 
macs
AngII CD14-/-
macs
Saline AngII treated
CD14-/- macs
CD14+/+ macs
# 
ce
lls
/s
ec
tio
n
*
Adventitia Intima Adventitia Intima 
Figure 2. A, Deletion of CD14 reduced the incidence of AAA and TAA induced by AngII infusion (left). Effects of CD14 deletion on AAA diameter
and weight (right). B, Representative gross images of aortas harvested from saline-infused (control, n=7) and from AngII-infused mice (CD14+/+,
n=16; CD14/, n=7). C, Representative H&E staining and D, macrophage immunostaining (lower) in suprarenal and thoracic aortic segments.
E, Representative images of CD14+/+ and CD14/ monocyte binding to aortic segments from saline- and AngII-infused mice with accompanying
bar graph of quantiﬁcation. AAA indicates abdominal aortic aneurysm; TAA, thoracic aortic aneurysm; AngII, angiotensin II; H&E, hematoxylin
and eosin.
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with IL-6, whereas migration to MCP-1 was unaffected
(Figure 3C).
CD14 Expression in Human AAA
We sought to validate whether CD14 expression is associated
with human AAAs. First, we compared CD14 expression in
segments of infrarenal AAAs and adjacent nonaneurysmal
tissues obtained from patients (n=3) undergoing elective AAA
repair. As expected, the tissue was severely degenerated, in
keeping with the end-stage nature of the disease. Examination
of tissue histology showed atherosclerotic changes (ie,
neointimal proliferation, foam cell formation) in both AAAs
and nonaneurysmal sections of aorta, whereas inﬂammation,
medial degeneration, and oxidative stress were prominent in
the AAA tissues, as has been previously reported by Miller
et al.32 Aortic tissue sections were immunostained for CD14,
which showed increased expression in AAA compared with non-
aneurysmal aortic tissues from the same patient (Figure 4A);
immunostaining was not detected in the negative controls
without primary antibody (not shown). CD14 expression was
increased throughout all layers of AAA and colocalized with
macrophages (Figure 4B). Second, we sought to translate
these observations to an available medical-monitored cohort
with banked serum samples. We were able to identify a
group of patients with AAAs documented by aortic imaging
and/or surgical pathology and compared serum sCD14
concentrations to age- and sex-matched control patients in
whom the absence of AAA was veriﬁed by aortic imaging.
As shown in Figure 4C, although there was considerable
variability, sCD14 concentrations were higher in AAA cases
compared with controls (28 control patients and 21 patients
with AAAs) when evaluated by the Mann–Whitney U test
(P=0.02). Together, these data suggest that CD14 expres-
sion may be locally and systemically upregulated in human
AAA.
Discussion
The innate immune signaling molecule CD14 is both a marker
for monocytes/macrophages and a transducer of immune
responses. We report that CD14 is requisite for adventitial
recruitment of macrophage precursors leading to aneurysm
formation. To our knowledge, this is the ﬁrst report demon-
strating a conﬁrmed role for CD14 in the pathogenesis of
vascular disease.
The innate immune system is the ﬁrst line of defense for
invading microorganisms and has been shown to be involved
in atherosclerotic disease9,33 TLRs are central to this process
by recognizing pathogen-associated molecular patterns
(PAMPs), including bacterial endotoxin. Responses to LPS
are enhanced by CD14, which, in cooperation with LPS-
binding protein, facilitates binding and transfer of endotoxin
to the TLR4/MD-2 complex.34 CD14 is expressed on several
cell types including neutrophils, dendritic cells, lymphocytes,
and even nonmyeloid cells, but at concentrations much less
than on monocytes and macrophages.35 Mice deﬁcient in
CD14 exhibit reduced systemic inﬂammation and improved
survival in response to injected endotoxin, indicating the
importance of CD14 in endotoxin signaling in vivo.36
Combined inhibition of CD14 and complement dramatically
reduced inﬂammation induced by Escherichia coli in pig whole
blood, suggesting a promising strategy to treat gram-negative
sepsis.37 In vitro studies indicate that smooth LPS requires
CD14 for activation of downstream inﬂammatory signaling
through the TRIF/TRAM pathway. In contrast, the lipid A
molecule (rough LPS) can activate TLR4 in the absence of
CD14 through recruitment of MyD88 and Mal.38
The classic CD14 ligand is bacterial endotoxin, which has
been suggested to play a role in AAA formation in humans and
mice.39 However, other factors in the AAA milieu may also
contribute to the disease process in a CD14-dependent
manner. For example, cell-surface CD14 speciﬁcally binds
minimally modiﬁed (oxidized) LDL, which plays an important
role in vascular disease.33,40 CD14 has been postulated to
play a role in delivering TLR ligands to lipid raft microdomains,
thereby facilitating interactions with kinases and G-proteins
coupled to inﬂammatory signaling.41,42 Also, CD14 has been
demonstrated to mediate monocyte-induced T-cell activation
and monocyte binding to cytokine-stimulated endothelial
cells, suggesting that this molecule regulates many aspects
of inﬂammation pertinent to cardiovascular diseases such as
atherosclerosis and AAA.43 Although the ﬁndings of this study
clearly implicate CD14 in the pathogenesis of AAA, identiﬁ-
cation of the speciﬁc CD14 ligands and downstream signaling
pathways remains to be determined.
Several studies have suggested an important role for
innate immunity in the formation of atherosclerotic dis-
ease.44,45 However, as in AAA, the speciﬁc PAMPs involved,
receptors, coreceptors, and adaptor proteins that transduce
the inﬂammatory signals, remain to be fully elucidated. In
addition to bacterial products produced during indolent
infections, modiﬁed host ligands, such as dying cells and
oxidized lipid molecules present in the atherosclerotic milieu,
likely serve as PAMPs in the setting of atherosclerosis.46,47
Consistent with this notion, TLR2, TLR4, and the TLR4 adaptor
protein MyD88 have been implicated in the pathogenesis of
atherosclerosis in murine models.9,33,48 Because CD14 inter-
acts with both TLR4 and TLR2 and mediates cytokine-induced
monocyte adherence to endothelial cells, it would seem
intuitive that CD14 should also be involved in atherosclerosis.
However, Bjorkbacka et al9 showed that deletion of CD14 had
no impact on aortic root atherosclerosis in apoE/ mice.
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In contrast to the data suggesting a lack of involvement of
CD14 in atherosclerosis, we provide compelling evidence that
CD14 is intimately involved in AAA formation. We chose 2
complementary murine models in which to address our
hypothesis: intra-aortic elastase infusion and systemic AngII
infusion in hyperlipidemic mice. As is the case with many
small-animal models of human disease, these models have
unique strengths and weaknesses, and neither recapitulates
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Figure 3. All experiments were performed in triplicate. A, Cumulative data (left), representative histogram (middle), and dot blots (right) showing
effects of IL-6- and PVAT-conditioned media on CD14 expression in THP-1 cells. The green outline peak represents the expected background
staining, or “unstained control.” The ﬁlled-in purple curves show the response of the isotype control (top) as the negative control or the IL-6
(bottom). B, Migratory responses to LAM-, MCP-1-, AoAf-, and PVAT-conditioned media in THP-1 cells with and without CD14 blocking CD14 (left
panel), and in peritoneal macrophages from CD14+/+ and CD14/ mice (right panel). Note that different concentrations of MCP-1 were used in
these experiments employing THP-1 cells (left) or murine peritoneal macrophages (right). C, Cumulative data (left) and representative images
showing effects of IL-6 preincubation on migration of THP-1 cells in response to 2 concentrations of LAM-, MCP-1-, and AoAf-conditioned media.
IL indicates interleukin; LAM, lipoarabinomannan; MCP-1, monocyte chemotactic protein; PVAT, perivascular adipose tissue; AoAf, aortic
adventitial ﬁbroblast; THP-1, human acute monocytic leukemia cell line.
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all features of human AAA with complete ﬁdelity. The elastase
infusion model bears many similarities to human AAA,
including inﬂammatory cell inﬁltration, MMP activation, and
elastin degradation. However, rupture and thrombus forma-
tion are uncommon in this model. In contrast, rupture and
thrombus formation occur frequently in the AngII infusion
model, although the location tends to be medial and/or
adventitial rather than luminal, which is perhaps more
consistent with aortic dissection rather than AAA. In addition,
AAA induced by AngII infusion is, like human AAA, more
prevalent in men and positively inﬂuenced by hyperlipid-
emia.20 That mice lacking CD14 were protected against AAA
formation induced by intra-aortic elastase infusion and
systemic AngII infusion suggests that CD14 is required for
pathological processes common to both experimental models.
Deletion of CD14 had little impact on activation of MMP-2/9,
key proteases involved in matrix degradation leading to aortic
expansion. In contrast, adventitial macrophage precursor
recruitment, a key initiating step in both models of AAA
formation, was strongly abrogated in mice lacking CD14.
Very little is known about mechanisms that regulate
adventitial inﬂammation in diseases such as AAA. Adventitial
cells, including AoAf and perivascular adipocytes, are active
participants in this process, secreting factors that contribute to
matrix remodeling and inﬂammatory cell recruitment.30 Indeed,
we previously reported that perivascular adipocytes secrete
higher levels of proinﬂammatory cytokines than subcutaneous
or visceral adipocytes.30 Here, we have provided novel insight
into mechanistic interactions by demonstrating that factors
secreted by adventitial cells upregulatemonocyte expression of
CD14, which in turn directs monocyte migration. We have
further demonstrated that IL-6 potently upregulates CD14
expression, whereas MCP-1 and osteopontin, proinﬂammatory
cytokines that are also implicated in AAA, do not. IL-6 is a key
inﬂammatory cytokine in AAA formation.49 In the murine AngII
infusion model, IL-6 expression was highest in the adventitia
and correlated anatomically with macrophage precursor
recruitment.50,51 Also, expression of IL-6 was markedly
increased in human AAA compared with atherosclerotic,
nonaneurysmal aorta.12,29 Further, we observed that CD14
expressionwasmuch higher in humanAAA and colocalized with
macrophages and that monocyte binding to AngII-infused aorta
was CD14 dependent. Collectively, these ﬁndings suggest that
IL-6 and CD14 participate in a proinﬂammatory feed-forward
loop that promotes adventitial inﬂammation in AAA.
In summary, we report that the innate immune signaling
molecule CD14 plays a key role in the pathogenesis of AAA.
Expression of CD14 mediates macrophage precursor recruit-
ment to the aortic adventitia in response to soluble factors
such as IL-6 released by ﬁbroblasts and perivascular adipo-
cytes. Expression of CD14 is both locally and systemically
upregulated in human AAA. Thus, targeting CD14-dependent
inﬂammatory responses could represent a fruitful approach to
treating AAA in humans.
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